Integrins in angiogenesis and lymphangiogenesis (original) (raw)

• Carmeliet, P. Angiogenesis in life, disease and medicine, Nature 42, 932–936 (2005).
  Google Scholar
• Adams, R. H. & Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nature Rev. Mol. Cell Biol. 8, 464–478 (2007).
  CAS Google Scholar
• Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 11, 1194–1201 (2001). This article established the concept that bone marrow-derived cells in lung and other tissues could help create an environment that attracts metastatic tumour cells.
  Google Scholar
• Schmid, M. C. & Varner, J. A. Myeloid cell trafficking and tumor angiogenesis. Cancer Lett. 250, 1–8 (2007).
  CAS PubMed Google Scholar
• Lin, E. Y. & Pollard, J. W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67, 5064–5066 (2007). This article shows that macrophages have crucial roles in altering the fate of tumours by secreting pro-angiogenic growth factors.
  CAS PubMed Google Scholar
• Ferrara, N. & Kerbel, R. S. Angiogenesis as a therapeutic target. Nature 438, 967–974 (2005).
  CAS PubMed Google Scholar
• Roma, A. A. et. al. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod. Pathol. 19, 392–398 (2006).
  PubMed Google Scholar
• Dadras, S. S. et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 18, 1232–1242 (2005).
  PubMed Google Scholar
• Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089–1099 (2005). This article showed for the first time that tumors induce lymphangiogenesis not only in the peritumoural space but also in draining lymph nodes.
  CAS PubMed PubMed Central Google Scholar
• Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002).
  CAS PubMed Google Scholar
• Plow, E. F. et al. Ligand binding to integrins. J. Biol. Chem. 275, 21785–21788 (2000).
  CAS PubMed Google Scholar
• Haas, T. A. & Plow, E. F. Integrin–ligand interactions: a year in review. Curr Opin Cell Biol. 6, 656–662 (1994).
  CAS PubMed Google Scholar
• Komoriya, A. et al. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine–aspartic acid–valine. J. Biol. Chem. 266, 15075–15079 (1991).
  CAS PubMed Google Scholar
• Jin, H. & Varner, J. Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 90, 561–565 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nature Rev. Mol. Cell. Biol. 6, 56–68 (2005).
  CAS Google Scholar
• Mitra, S. K & Schlaepfer, D. D. Integrin-regulated FAK–Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516–523 (2006).
  CAS PubMed Google Scholar
• Stupack, D. G. Integrins as a distinct subtype of dependence receptors. Cell Death Differ. 12, 1021–1030 (2005).
  CAS PubMed Google Scholar
• Zhu, J. et al. β8 integrins are required for vascular morphogenesis in mouse embryos. Development 129, 2891–2903 (2002). This article shows that integrin αvb8 is required for the formation of normal brain blood vessels.
  CAS PubMed Google Scholar
• Cheresh, D. A. Human endothelial cells synthesize and express an Arg–Gly–Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc. Natl Acad. Sci. USA 84, 6471–6475 (1987).
  CAS PubMed PubMed Central Google Scholar
• Brooks, P. C., Clark, R. A. & Cheresh, D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569–571 (1994). This is the first article demonstrating a role for an integrin in angiogenesis.
  CAS PubMed Google Scholar
• Brooks, P. C. et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994).
  CAS PubMed Google Scholar
• Brooks, P. C. et al. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815–1822 (1995).
  CAS PubMed PubMed Central Google Scholar
• Friedlander, M. et al. Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500–1502 (1995). This article established that two unique pathways of angiogenesis are regulated by two distinct αv integrins.
  CAS PubMed Google Scholar
• Friedlander, M. et al. Involvement of integrins αvβ3 and αvβ5 in ocular neovascular diseases. Proc. Natl Acad. Sci. USA 93, 9764–9769 (1996).
  CAS PubMed PubMed Central Google Scholar
• Friedlander, M. et al. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Invest. Ophthalmol. Vis. Sci. 48, 5184–5190 (2007).
  Google Scholar
• Drake, C. J., Cheresh, D. A. & Little, C. D. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108, 2655–2661 (1995).
  CAS PubMed Google Scholar
• Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C. & Cheresh. D. A. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Invest. 98, 426–433 (1996).
  PubMed PubMed Central Google Scholar
• Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M. & Cheresh, D. A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459–470 (2001). This article established the concept of integrin-mediated death by showing that unligated integrins promote cell death.
  CAS PubMed PubMed Central Google Scholar
• Eliceiri, B. P, Klemke, R., Strömblad, S. & Cheresh, D. A. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140, 1255–1263 (1998).
  CAS PubMed PubMed Central Google Scholar
• Eliceiri, B. P. et al. Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling. J. Cell Biol. 157, 149–160 (2002).
  CAS PubMed PubMed Central Google Scholar
• Seker, A. et al. Expression of integrins in cerebral arteriovenous and cavernous malformations. Neurosurgery 58, 159–168 (2006).
  PubMed Google Scholar
• Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024–1028 (1995).
  CAS PubMed Google Scholar
• Weis, S., Cui, J., Barnes, L. & Cheresh, D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 167, 223–232 (2004).
  CAS PubMed PubMed Central Google Scholar
• Criscuoli, M. L., Nguyen, M. & Eliceiri, B. P. Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood 105, 1508–1514 (2005).
  CAS PubMed Google Scholar
• Hodivala-Dilke, K. M. et al. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103, 229–238 (1999).
  CAS PubMed PubMed Central Google Scholar
• Weis, S. M. et al. Cooperation between VEGF and β3 integrin during cardiac vascular development. Blood 109, 1962–1970 (2007).
  CAS PubMed PubMed Central Google Scholar
• Reynolds, L. E. et al. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nature Med. 8, 27–34 (2002).
  CAS PubMed Google Scholar
• Reynolds, A. R. et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice. Cancer Res. 64, 8643–8650 (2004). This study established the concept that developmental loss of an integrin could lead to enhanced angiogenesis through compensatory mechanisms.
  CAS PubMed Google Scholar
• Huang, X., Griffiths, M., Wu, J., Farese, R. V. Jr & Sheppard, D. Normal development, wound healing, and adenovirus susceptibility in β5-deficient mice. Mol. Cell Biol. 20, 755–759 (2000). This article showed that loss of αvb5 during development has no significant effect on angiogenesis.
  CAS PubMed PubMed Central Google Scholar
• Bader, B. L., Rayburn, H., Crowley, D. & Hynes, R. O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell 95, 507–519 (1998). This study shows that αv integrins are essential for development in most animals but that some animals can survive in ovo loss of αv integrins until the early post-natal period.
  CAS PubMed Google Scholar
• McCarty, J. H. et al. Selective ablation of α v integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development 132, 165–176 (2005).
  CAS PubMed Google Scholar
• McCarty, J. H. et al. Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking αv integrins. Mol. Cell. Biol. 22, 7667–7677 (2002).
  CAS PubMed PubMed Central Google Scholar
• Mahabeleshwar, G. H., Feng, W., Phillips, D. R. & Byzova, T. V. Integrin signaling is critical for pathological angiogenesis. J. Exp. Med. 203, 2495–2507 (2006). This study shows that animals with an intact but non-functional β3 integrin exhibit defective angiogenesis.
  CAS PubMed PubMed Central Google Scholar
• Montgomery, A. M., Reisfeld, R. A. & Cheresh, D. A. Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl Acad. Sci. USA 91, 8856–8860 (1994).
  CAS PubMed PubMed Central Google Scholar
• Clark, R. A. et al. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J. Invest. Dermatol. 79, 269–276 (1982).
  CAS PubMed Google Scholar
• Kim, S., Bell, K., Mousa, S. A. & Varner, J. A. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156, 1345–1362 (2000). This is the first article showing a role for integrin α5b1 in angiogenesis.
  CAS PubMed PubMed Central Google Scholar
• Liao, Y. F., Gotwals, P. J., Koteliansky, V. E., Sheppard, D. & Van De Water, L. The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 277, 14467–14474 (2002).
  CAS PubMed Google Scholar
• George, E. L., Baldwin, H. S. & Hynes, R. O. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 90, 3073–3081 (1997).
  CAS PubMed Google Scholar
• Astrof, S., Crowley, D. & Hynes, R. O. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev. Biol. 311, 11–24 (2007).
  CAS PubMed PubMed Central Google Scholar
• Fassler, R. & Meyer, M. Consequences of lack of β1 integrin gene expression in mice. Genes Dev. 9, 1896–1908 (1995).
  CAS PubMed Google Scholar
• Stephens, L. E. et al. Deletion of β1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 9, 1883–1895 (1995).
  CAS PubMed Google Scholar
• Tanjore, H., Zeisberg, E. M., Gerami-Naini, B. & Kalluri, R. β1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev. Dyn. 237, 75–82 (2007).
  Google Scholar
• Bloch, W. et al. β1 integrin is essential for teratoma growth and angiogenesis. J. Cell Biol. 139, 265–278 (1997).
  CAS PubMed PubMed Central Google Scholar
• Muether, P. S. et al. The role of integrin α5β1 in the regulation of corneal neovascularization. Exp. Eye Res. 85, 356–365 (2007).
  CAS PubMed Google Scholar
• Boudreau, N. J. & Varner, J. A. The homeobox transcription factor Hox D3 promotes integrin α5β1 expression and function during angiogenesis. J. Biol. Chem. 279, 4862–4868 (2004).
  CAS PubMed Google Scholar
• Umeda, N. et al. Suppression and regression of choroidal neovascularization by systemic administration of an α5β1 integrin antagonist. Mol. Pharmacol. 69, 1820–1828 (2006).
  CAS PubMed Google Scholar
• Kim, S., Harris, M. & Varner, J. A. Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A. J. Biol. Chem. 275, 33920–33928 (2000).
  CAS PubMed Google Scholar
• Kim, S., Bakre, M., Yin, H. & Varner, J. A. Inhibition of endothelial cell survival and angiogenesis by protein kinase, A. J. Clin. Invest. 110, 933–941 (2002).
  CAS PubMed PubMed Central Google Scholar
• Yang, J. T., Rayburn, H. & Hynes, R. O. Embryonic mesodermal defects in α5 integrin-deficient mice. Development 119, 1093–1105 (1993). This article shows that integrin α5 is required during embryonic development of early blood vessels and other tissues.
  CAS PubMed Google Scholar
• Taverna, D. & Hynes, R. O. Reduced blood vessel formation and tumor growth in α5-integrin-negative teratocarcinomas and embryoid bodies. Cancer Res. 61, 5255–5261 (2001).
  CAS PubMed Google Scholar
• Francis, S. E. et al. Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22, 927–933 (2002).
  CAS PubMed Google Scholar
• Yang, J. T., Rayburn, H. & Hynes, R. O. Cell adhesion events mediated by α 4 integrins are essential in placental and cardiac development. Development 121, 549–560 (1995).
  CAS PubMed Google Scholar
• Garmy-Susini, B. et al. Integrin α4β1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J. Clin. Invest. 115, 1542–1551 (2005). This article demonstrates that integrin α4β1 on endothelium promotes endothelial cell motility and angiogenesis as well as a transient association of pericytes with endothelium.
  CAS PubMed PubMed Central Google Scholar
• Vlahakis, N. E. et al. Integrin α9β1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J. Biol. Chem. 282, 15187–15196 (2007).
  CAS PubMed Google Scholar
• Staniszewska, I. et al. Interaction of α9β1 integrin with thrombospondin-1 promotes angiogenesis. Circ. Res. 100, 1308–1316 (2007).
  CAS PubMed Google Scholar
• Liao, Y. F. et al. The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 277, 14467–14474 (2002).
  CAS PubMed Google Scholar
• Marcinkiewicz, C. et al. Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin α9β1 with VCAM-1, tenascin-C, and osteopontin. J. Biol. Chem. 275, 31930–31937 (2000).
  CAS PubMed Google Scholar
• Huang, X. Z. et al. Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol. Cell. Biol. 20, 5208–5215 (2000). This study demonstrates that integrin α9b1 is required for proper development of the lymphatic system.
  CAS PubMed PubMed Central Google Scholar
• Senger, D. R. et al. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc. Natl Acad. Sci. USA 94, 13612–13617 (1997).
  CAS PubMed PubMed Central Google Scholar
• Pozzi, A. et al. Elevated matrix metalloprotease and angiostatin levels in integrin α1-knockout mice cause reduced tumor vascularization. Proc. Natl Acad. Sci. USA 97, 2202–2207 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Z. et al. α2β1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor-cell specific manner. Blood 111, 1980–1988 (2008). This paper shows that integrin α2b1-null mice exhibit distinct tumour growth patterns that are dependent upon the growth factors that are intrinsically expressed by individual tumour cells.
  CAS PubMed PubMed Central Google Scholar
• Lee, T. H. et al. Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells: role of α6β1 integrin in angiogenesis. J. Biol. Chem. 281, 40450–40460 (2006).
  CAS PubMed Google Scholar
• Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W. & Giancotti, F. G. Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6, 471–483 (2004). This paper shows the important role of integrin α6b4 in angiogenesis.
  CAS PubMed Google Scholar
• van der Neut, R., Krimpenfort, P., Calafat, J., Niessen, C. M. & Sonnenberg, A. Epithelial detachment due to absence of hemidesmosomes in integrin β4-null mice. Nature Genet. 13, 366–369 (1996).
  CAS PubMed Google Scholar
• Georges-Labouesse, E. et al. Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nature Genet. 13, 370–373 (1996).
  CAS PubMed Google Scholar
• Dowling, J., Yu, Q. C. & Fuchs, E. β4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J. Cell Biol. 134, 559–572 (1996).
  CAS PubMed Google Scholar
• Dans, M., et al. Tyrosine phosphorylation of the β4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes. J. Biol. Chem. 276, 1494–1502 (2001).
  CAS PubMed Google Scholar
• Leu, S. J. et al. Identification of a novel integrin α6β1 binding site in the angiogenic inducer CCN1 (CYR61). J. Biol. Chem. 278, 33801–33808 (2003).
  CAS PubMed Google Scholar
• Jin, H. et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J. Clin. Invest. 116, 652–662 (2006). This paper shows that integrin α4b1 on bone marrow-derived cells promotes monocyte and endothelial precursor cell homing to tumours.
  CAS PubMed PubMed Central Google Scholar
• Jin, H., Su, J., Garmy-Susini, B., Kleeman, J. & Varner, J. Integrin α4β1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res. 66, 2146–2152 (2006).
  CAS PubMed Google Scholar
• Wu, Y. et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ. Res. 99, 315–322 (2006).
  CAS PubMed Google Scholar
• Chavakis, E. et al. Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med. 1, 63–72 (2005).
  Google Scholar
• Varner, J. A. The sticky truth about angiogenesis and thrombospondins. J. Clin. Invest. 116, 3111–3113 (2006).
  CAS PubMed PubMed Central Google Scholar
• Kopp, H. G. & Rafii, S. Thrombopoietic cells and the bone marrow vascular niche. Ann. NY Acad. Sci. 1106, 175–179 (2007).
  CAS PubMed Google Scholar
• Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789–801 (1999).
  CAS PubMed PubMed Central Google Scholar
• Wigle, J. T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769–778 (1999).
  CAS PubMed Google Scholar
• Breiteneder-Geleff, S. et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154, 385–394 (1999).
  CAS PubMed PubMed Central Google Scholar
• Mishima, K. et al. Prox1 induces lymphatic endothelial differentiation via integrin α9 and other signaling cascades. Mol. Biol. Cell. 18, 1421–1429 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vlahakis, N. E., Young, B. A., Atakilit, A. & Sheppard, D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin α9β1. J. Biol. Chem. 280, 4544–4552 (2005).
  CAS PubMed Google Scholar
• Hong, Y. K. et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the α1β1 and α2β1 integrins. FASEB J. 18, 1111–1113 (2004). This article established the role of integrins α1b1 and α2b1 in lymphangiogenesis.
  CAS PubMed Google Scholar
• Dietrich, T. et al. Inhibition of inflammatory lymphangiogenesis by integrin α5 blockade. Am. J. Pathol. 171, 361–372 (2007).
  CAS PubMed PubMed Central Google Scholar
• Garmy-Susini, B., Makale, M., Fuster, M. & Varner, J. A. Methods to study lymphatic vessel integrins. Methods Enzymol. 426, 415–438 (2007).
  CAS PubMed Google Scholar
• Gutheil, J. C. et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3. Clin. Cancer Res. 6, 3056–3061 (2000).
  CAS PubMed Google Scholar
• McNeel, D. G. et al. Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res. 11, 7851–7860 (2005).
  CAS PubMed Google Scholar
• Hersey, P. et al. A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human αvβ3 (αvβ3) integrin, ± dacarbazine (DTIC) in patients with metastatic melanoma. J. Clin. Oncol. 2005 ASCO Annu. Meeting Proc. 23, 7507 (2005).
  Google Scholar
• Zhang, D., Pier, T., McNeel, D. G., Wilding, G. & Friedl, A. Effects of a monoclonal anti-αvβ3 integrin antibody on blood vessels — a pharmacodynamic study. Invest. New Drugs 25, 49–55 (2007).
  CAS PubMed Google Scholar
• Trikha, M. et al. CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo. Int. J. Cancer 110, 326–335 (2004).
  CAS PubMed Google Scholar
• Martin, P. L. et al. Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-αv integrin monoclonal antibody, despite widespread tissue binding. Clin. Cancer Res. 11, 6959–6965 (2005).
  CAS PubMed Google Scholar
• Mullamitha, S. A. et al. Phase I evaluation of a fully human anti-αv integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin. Cancer Res. 13, 2128–2135 (2007).
  CAS PubMed Google Scholar
• Brooks, P. C. et al. Insulin-like growth factor receptor cooperates with integrin αvβ5 to promote tumor cell dissemination in vivo. J. Clin. Invest. 99, 1390–1398 (1997).
  CAS PubMed PubMed Central Google Scholar
• Nabors, L. B. et al. Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. J. Clin. Oncol. 25, 1651–1657 (2007).
  CAS PubMed Google Scholar
• Albert, J. M. et al. Integrin α v β 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int. J. Radiat. Oncol. Biol. Phys. 65, 1536–1543 (2006).
  CAS PubMed Google Scholar
• Friess, H. et al. A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BMC Cancer 6, 285 (2006).
  PubMed PubMed Central Google Scholar
• Beekman, K. W. et al. Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design. Clin. Genitourin. Cancer 4, 299–302 (2006).
  CAS PubMed Google Scholar
• Bradley, D. A. et. al. EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372). J. Clin. Oncol. 2007 ASCO Annu. Meeting Proc. 25, 5137 (2007).
  Google Scholar
• Figlin, R. A., Kondagunta, G. V., Yazji, S., Motzer, R. J. & Bukowski, R. M. Phase II study of volociximab (M200), an α5β1 anti-integrin antibody in refractory metastatic clear cell renal cell cancer (RCC). J. Clin. Oncol. ASCO Annu. Meeting Proc. 24, 4535 (2006).
  Google Scholar
• Kuwada, S. K. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr. Opin. Mol. Ther. 9, 92–98 (2007).
  CAS PubMed Google Scholar
• Stoeltzing, O. et al. Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int. J. Cancer 104, 496–503 (2003).
  CAS PubMed Google Scholar
• Cianfrocca, M. E. et al. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a β integrin antagonist, in patients with solid tumours. Br. J. Cancer 94, 1621–1626 (2006).
  CAS PubMed PubMed Central Google Scholar
• Lim, E. H., Danth, N., Bednarski, M. & Li, K. C. A review: Integrin αvβ3-targeted molecular imaging and therapy in angiogenesis. Nanomedicine 1, 110–114 (2005).
  CAS PubMed Google Scholar
• Garanger, E., Boturyn, D. & Dumy, P. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. Anticancer Agents Med. Chem. 7, 552–558 (2007).
  CAS PubMed Google Scholar
• Sipkins, D. A. et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nature Med. 4, 623–626 (1998).
  CAS PubMed Google Scholar
• Leong-Poi, H. et al. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to αv-integrins. Circulation 107, 455–460 (2003).
  CAS PubMed Google Scholar
• Hood, J. D. et al. Tumor regression by targeted gene delivery to the neovasculature. Science 296, 2404–2407 (2002). This landmark paper established the potential of integrin-targeted nanoparticles in cancer therapy.
  CAS PubMed Google Scholar
• Arnaout, M. A., Mahalingam, B. & Xiong, J. P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381–410 (2005).
  CAS PubMed Google Scholar
• Lu, C., Takagi, J. & Springer, T. A. Association of the membrane proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state. J. Biol. Chem. 276, 14642–14648 (2001).
  CAS PubMed Google Scholar
• Beglova, N., Blacklow, S. C., Takagi, J. & Springer, T. A. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nature Struct. Biol. 9, 282–287 (2002).
  CAS PubMed Google Scholar
• Vinogradova, O. et al. A structural mechanism of integrin αIIbβ3 “inside-out” activation as regulated by its cytoplasmic face. Cell 110, 587–597 (2002).
  CAS PubMed Google Scholar
• Grabovsky, V. et al. Subsecond induction of α4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J. Exp. Med. 192, 495–506 (2000).
  CAS PubMed PubMed Central Google Scholar
• O'Toole, T. E. et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol. 124, 1047–1059 (1994).
  CAS PubMed Google Scholar
• Lin, E. Y. et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238–11246 (2006).
  CAS PubMed Google Scholar
• Lin, E. Y. & Pollard, J. W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67, 5064–5066 (2007).
  CAS PubMed Google Scholar
• Peng, X. et al. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovasc. Res. 64, 421–430 (2004).
  CAS PubMed Google Scholar
• Shen, T. L. et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J. Cell Biol. 169, 941–952 (2005).
  CAS PubMed PubMed Central Google Scholar
• Lai, K. M. & Pawson, T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev. 14, 1132–1145 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hüser, M. et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20, 1940–1951 (2001).
  PubMed PubMed Central Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  CAS PubMed PubMed Central Google Scholar
• Bolat, F. et al. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J. Exp. Clin. Cancer Res. 25, 365–372 (2006).
  CAS PubMed Google Scholar
• Tsutsui, S. et al. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol. Rep. 14, 425–431 (2005).
  CAS PubMed Google Scholar
• Valkovi´c, T. et al. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch. 440, 583–588 (2002).
  Google Scholar
• Esposito, I. et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinomas. J. Clin. Pathol. 6, 630–636 (2004).
  Google Scholar
• Leek, R. D. & Harris, A. L. Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 2, 177–189 (2002).
  Google Scholar
• Nishie, A. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin. Cancer Res. 5, 1107–1113 (1999).
  CAS PubMed Google Scholar
• Yamashiro, S. et al. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am. J. Pathol. 4, 856–867 (1994).
  Google Scholar
• Lewis, J. S. et al. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 2, 150–158 (2000).
  Google Scholar
• Sica, A. & Bronte, V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155–1166 (2007).
  CAS PubMed PubMed Central Google Scholar
• Jodele, S. et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res. 65, 3200–3208 (2005).
  CAS PubMed Google Scholar
• Giraudo, E., Inoue, M. & Hanahan, D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J. Clin. Invest. 5, 623–633 (2004).
  Google Scholar
• Ueno, T. et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 8, 3282–3289 (2000).
  Google Scholar
• Niwa, Y. et al. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin. Cancer Res. 2, 285–289 (2001).
  Google Scholar
• Murdoch, C., Giannoudis, A. & Lewis, C. E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 8, 2224–2234 (2004).
  Google Scholar
• Gerszten, R. E. et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718–723 (1999).
  CAS PubMed Google Scholar
• Goswami, S. et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 12, 5278–5283 (2005).
  Google Scholar
• Luo, J. L. et al. Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Nature 446, 690–694 (2007).
  CAS PubMed Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  CAS PubMed Google Scholar
• Schafer, Z. T. & Brugge, J. S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117, 3660–3663 (2007).
  CAS PubMed PubMed Central Google Scholar
• Sansone, P. et al. Il-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117, 3988–4002 (2007).
  CAS PubMed PubMed Central Google Scholar
• Gao, S. P. et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas J. Clin. Invest. 117, 3846–3856 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 6, 727–740 (2001).
  Google Scholar
• Lu, H. et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99, 1340–1350 (1997).
  CAS PubMed PubMed Central Google Scholar